KCNJ14 and cancer: Additionally, TMB and MSI were linked to KCNJ14 expression in a variety of human malignancies, which suggests that these findings may establish KCNJ14 as a robust predictive biomarker, a marker for patients’ response to immunotherapy, and a prospective target for cancer therapies.